 | • レポートコード：MRC2304J0234 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、244ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料によると、世界の薬物送達デバイス市場規模は、2021年1,891.8億ドルから2022年に2,072.7億ドルへと拡大、その後2027年までに年平均10.19％成長して3,386.7億ドルに達する見通しです。本書は、薬物送達デバイスの世界市場を対象とした調査・分析結果を整理したものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、投与経路別分析（吸入投与、注射投与、経鼻投与、接眼レンズ、経口投与）、媒介物別分析（デンドリマー、ハイドロゲル、リポソーム、メソポーラス材料、ミセル）、用途別分析（自己免疫疾患、心血管疾患、中枢神経系疾患、糖尿病、感染症）、エンドユーザー別分析（外来手術センター/クリニック、診断センター、在宅医療、病院）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目を掲載しています。なお、本書には、3M Company、Abbott Laboratories、Antares Pharma, Inc.、B. Braun Melsungen AG、Baxter International Inc.、Becton, Dickinson and Company、Eisai Co., Ltd.、Enable Injections, Inc.、Gerresheimer AG、GlaxoSmithKline PLC、Insulet Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の薬物送達デバイス市場規模：投与経路別 - 吸入投与の市場規模 - 注射投与の市場規模 - 経鼻投与の市場規模 - 接眼レンズの市場規模 - 経口投与の市場規模 ・世界の薬物送達デバイス市場規模：媒介物別 - デンドリマーの市場規模 - ハイドロゲルの市場規模 - リポソームの市場規模 - メソポーラス材料の市場規模 - ミセルの市場規模 ・世界の薬物送達デバイス市場規模：用途別 - 自己免疫疾患における市場規模 - 心血管疾患における市場規模 - 中枢神経系疾患における市場規模 - 糖尿病における市場規模 - 感染症における市場規模 ・世界の薬物送達デバイス市場規模：エンドユーザー別 - 外来手術センター/クリニックにおける市場規模 - 診断センターにおける市場規模 - 在宅医療における市場規模 - 病院における市場規模 ・世界の薬物送達デバイス市場規模：地域別 - 南北アメリカの薬物送達デバイス市場規模 アメリカの薬物送達デバイス市場規模 カナダの薬物送達デバイス市場規模 ブラジルの薬物送達デバイス市場規模 ... - アジア太平洋の薬物送達デバイス市場規模 日本の薬物送達デバイス市場規模 中国の薬物送達デバイス市場規模 インドの薬物送達デバイス市場規模 韓国の薬物送達デバイス市場規模 台湾の薬物送達デバイス市場規模 ... - ヨーロッパ/中東/アフリカの薬物送達デバイス市場規模 イギリスの薬物送達デバイス市場規模 ドイツの薬物送達デバイス市場規模 フランスの薬物送達デバイス市場規模 ロシアの薬物送達デバイス市場規模 ... - その他地域の薬物送達デバイス市場規模 ・競争状況 ・企業情報 |
The Global Drug Delivery Devices Market size was estimated at USD 189.18 billion in 2021 and expected to reach USD 207.27 billion in 2022, and is projected to grow at a CAGR 10.19% to reach USD 338.67 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Drug Delivery Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Route of Administration, the market was studied across Inhalation, Injectable, Nasal, Ocular, Oral, Topical, and Transdermal.
Based on Vehicles, the market was studied across Dendrimer, Hydrogel, Liposome, Mesoporous Material, Micelle, Nanoparticle, Niosomes, and Scaffold.
Based on Application, the market was studied across Autoimmune Diseases, Cardiovascular Diseases, Central Nervous System Disorders, Diabetes, Infectious Diseases, Oncology, and Respiratory Diseases.
Based on End-user, the market was studied across Ambulatory Surgery Centers/Clinics, Diagnostic Centers, Home Care Settings, and Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, Minnesota, New Jersey, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Drug Delivery Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Drug Delivery Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Drug Delivery Devices Market, including 3M Company, Abbott Laboratories, Antares Pharma, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Eisai Co., Ltd., Enable Injections, Inc., Gerresheimer AG, GlaxoSmithKline PLC, Insulet Corporation, Koninklijke Philips N.V., OraSure Technologies, Inc., Smiths Medical, Inc., and West Pharmaceutical Services, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Drug Delivery Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Delivery Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Delivery Devices Market?
4. What is the competitive strategic window for opportunities in the Global Drug Delivery Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Drug Delivery Devices Market?
6. What is the market share of the leading vendors in the Global Drug Delivery Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Drug Delivery Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Chronic Diseases Globally Resulting in Increased Demand for Drug Delivery Devices
5.1.1.2. Rise in the Consumption of Drugs and Therapeutic Pharmaceuticals
5.1.2. Restraints
5.1.2.1. Increase in Complications and Expertise Required in Delivering Therapeutics and Drugs
5.1.3. Opportunities
5.1.3.1. Technology Advances in Drug Delivery Devices
5.1.3.2. Rising Adoption of Self Injectable Devices
5.1.4. Challenges
5.1.4.1. Increasing Cost of High End Products
5.2. Cumulative Impact of COVID-19
6. Drug Delivery Devices Market, by Route of Administration
6.1. Introduction
6.2. Inhalation
6.3. Injectable
6.4. Nasal
6.5. Ocular
6.6. Oral
6.7. Topical
6.8. Transdermal
7. Drug Delivery Devices Market, by Vehicles
7.1. Introduction
7.2. Dendrimer
7.3. Hydrogel
7.4. Liposome
7.5. Mesoporous Material
7.6. Micelle
7.7. Nanoparticle
7.8. Niosomes
7.9. Scaffold
8. Drug Delivery Devices Market, by Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cardiovascular Diseases
8.4. Central Nervous System Disorders
8.5. Diabetes
8.6. Infectious Diseases
8.7. Oncology
8.8. Respiratory Diseases
9. Drug Delivery Devices Market, by End-user
9.1. Introduction
9.2. Ambulatory Surgery Centers/Clinics
9.3. Diagnostic Centers
9.4. Home Care Settings
9.5. Hospitals
10. Americas Drug Delivery Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Drug Delivery Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Drug Delivery Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. 3M Company
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Abbott Laboratories
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Antares Pharma, Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. B. Braun Melsungen AG
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Baxter International Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Becton, Dickinson and Company
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Eisai Co., Ltd.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Enable Injections, Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Gerresheimer AG
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. GlaxoSmithKline PLC
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Insulet Corporation
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Koninklijke Philips N.V.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. OraSure Technologies, Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Smiths Medical, Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. West Pharmaceutical Services, Inc.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing